Personalising pancreas cancer treatment: When tissue is the issue

The treatment of advanced pancreatic cancer has not moved much beyond single agent gemcitabine until recently when protocols such as FOLFIRINOX (fluorouracil, leucovorin, irinotecan and oxaliplatin) and nab-paclitaxel-gemcitabine have demonstrated some improved outcomes. Advances in technology espec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sjoquist, Katrin M, Chin, Venessa T, Chantrill, Lorraine A, O’Connor, Chelsie, Hemmings, Chris, Chang, David K, Chou, Angela, Pajic, Marina, Johns, Amber L, Nagrial, Adnan M, Biankin, Andrew V, Yip, Desmond
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2014
Assuntos:
Topic Highlight
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4069313/
https://ncbi.nlm.nih.gov/pubmed/24976722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i24.7849
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados